Posaconazole for treatment of refractory invasive fungal disease.
2006
Summary
Invasive fungal infections are usually associated with immunocompromised states About 40–60% of these patients are refractory to standard antifungal therapy We describe the effect of posoconazole in the treatment of a 12 years-old girl with uncontrolled diabetes mellitus with life-threatening cerebral mucor mycosis and a 4 year old girl boy with chronic granulomatous disease presenting with invasive Aspergillus nidulans infection.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
38
Citations
NaN
KQI